Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the presence of a serum monoclonal protein (M-protein) less than 3 g/dL; fewer than 10 percent plasma cells in the bone marrow; no or only small amounts of M-protein (Bence Jones protein) in the urine; absence of lytic lesions, anemia, hypercalcemia, and renal insufficiency; and most importantly, stability of the M-protein and failure of development of other abnormalities. Detection of an M-protein is accomplished by electrophoresis on agarose or cellulose acetate followed by immunoelectrophoresis or immunofixation. The latter is more sensitive and is particularly useful when one is searching for a small M-protein (Kyle, 1994).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Axelsson U (1986) A 20-year follow up study of 64 subjects with M-components. Acta Med 219:519–522
Axelsson U, Bachman R, Hällén J (1966) Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 179:235–247
Belisle LM, Case DC Jr & Neveux L (1990) Quantitation of risk of malignant transformation in patients with “benign” monoclonal gammopathy (BMG) (Abstract). Blood 76(Suppl l):342a
Bladé J, Lopez-Guillermo A, Rozman C et al (1992) Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 81:391–394
Gabriel SE, O’Fallon WM, Kurland LT, Beard CM, Woods JE, Melton III LJ (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330:1697–1702
Giraldo MP, Rubio-Félix D, Perella M et al (1991) Aspectos clinicos, biológicos y evolutivos de 397 casos. Sangre 36:377–382
Kyle RA (1993) “Benign” monoclonal gammopathy—after 20 to 35 years of follow up. Mayo Clin Proc 68:26–36
Kyle RA (1994) The monoclonal gammopathies. Clin Chem 40:2154–2161
Kyle RA, Finkelstein S, Elveback LR, Kurland LT (1972) Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 40:719–724
Kyle RA, Beard CM, O’Fallon WM, Kurland LT (1994) Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. J Clin Oncol 12:1577–1583
Kyle RA, Greipp PR (1980) Series on clinical testing. 3. The laboratory investigation of monoclonal gammopathies. Mayo Clin Proc 53:719–739
Miller BA, Ries LA, Hankey BF, et al (1993) SEER Cancer Statistics Review 1973-1990. NIH Publ No. 93-2789, Bethesda, Maryland: NCI
Paladini G, Fogher M, Mazzanti G et al (1989) Idiopathic monoclonal gammopathy: long-term study of 313 cases. Recent Prog 80:123–132
Potter M, Morrison S, Wiener F, Zhang XK, Miller FW (1994) Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst 86:1058–1065
Saleun JP, Vicariot M, Deroff P (1982) Monoclonal gammopathies in the adult population of Finistère, France. J Clin Pathol 35:63–68
Salmon SE, Kyle RA (1994) Silicone gels, induction of plasma cell tumors, and genetic susceptibility in mice: a call for epidemiologic investigation of women with silicone breast implants. J Natl Cancer Inst 86:1042–1041
Witzig TE, Kyle RA & Greipp PR (1992) Circulating peripheral blood plasma cells in multiple myeloma. Curr Topics Microbiol Immunol 182:195–199
Witzig TE, Kyle RA, O’Fallon WM & Greipp PR (1994) Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol 87:266–272
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kyle, R.A. (1996). Monoclonal Gammopathy of Undetermined Significance. In: Potter, M., Rose, N.R. (eds) Immunology of Silicones. Current Topics in Microbiology and Immunology, vol 210. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85226-8_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-85226-8_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85228-2
Online ISBN: 978-3-642-85226-8
eBook Packages: Springer Book Archive